Cite
HARVARD Citation
Simpson, E. et al. (2020). Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. British journal of dermatology. pp. 242-255. [Online].